Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Shows utility in creating active pharmaceutical ingredients (APIs) targeting inflammatory diseases and neurological disorders due to its ability to cross the blood-brain barrier. Its trifluoromethyl group enhances metabolic stability and binding affinity in drug molecules. Also employed in agrochemical research for designing novel pesticides with improved efficacy and environmental safety. Commonly used in medicinal chemistry for structure-activity relationship (SAR) studies to optimize lead compounds.